Efficacy of a Single Intra-Articular HYMOVIS ONE Injection for Managing Symptomatic Hip Osteoarthritis: A 12-Month Follow-Up Retrospective Analysis of the ANTIAGE Register Data

References

• Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369. doi:10.1016/j.cger.2010.03.00120699159
   PubMed Web of Science ®Google Scholar
• Roman-Blas JA, Bizzi E, Largo R, Migliore A, Herrero-Beaumont G. An update on the up and coming therapies to treat osteoarthritis, a multifaceted disease. Expert Opin Pharmacother. 2016;17(13):1745–1756. doi:10.1080/14656566.2016.120107027326466
   PubMed Web of Science ®Google Scholar
• Nemes S, Gordon M, Rogmark C, Rolfson O. Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop. 2014;85(3):238–243. doi:10.3109/17453674.2014.91322424758323
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Ong KL, Lau E, Bozic KJ. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am. 2014;96(8):624–630. doi:10.2106/JBJS.M.0028524740658
   PubMed Web of Science ®Google Scholar
• Bagge E, Bjelle A, Valkenburg HA, Svanborg A. Prevalence of radiographic osteoarthritis in two elderly European populations. Rheumatol Int. 1992;12(1):33–38. doi:10.1007/BF002468741598499
   PubMed Web of Science ®Google Scholar
• Sperati A, Picconi O, Tancioni V, Guasticchi G, Agabiti N. Outcomes of hip replacement: a hospital-based longitudinal study in Lazio region (Italy). Ann Ig. 2008;20(2):141–157.18590046
   PubMedGoogle Scholar
• Zhang W, Doherty M, Arden N, et al.; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence-based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64(5):669–681. doi:10.1136/ard.2004.028886.15471891
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al.; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–474. doi:10.1002/acr.21596.22563589
   PubMed Web of Science ®Google Scholar
• Migliore A, Bizzi E, Herrero-Beaumont J, Petrella RJ, Raman R, Chevalier X. The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap!. Eur Rev Med Pharmacol Sci. 2015;19(7):1124–1129.25912569
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Raman R, Richette P, et al. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Semin Arthritis Rheum. 2015;45(2):140–149. doi:10.1016/j.semarthrit.2015.04.01126094903
   PubMed Web of Science ®Google Scholar
• Paoloni M, Bernetti A, Belelli A, et al. Appropriateness of clinical and organizational criteria for intra-articular injection therapies in osteoarthritis. A Delphi method consensus initiative among experts in Italy. Ann Ist Super Sanita. 2015;51(2):131–138. doi:10.4415/ANN_15_02_1126156184
   PubMed Web of Science ®Google Scholar
• Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsøe B, Torp-Pedersen S, Bliddal H. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthr Cartil. 2001;9:512–517. doi:10.1053/joca.2001.043311520164
   PubMed Web of Science ®Google Scholar
• Migliore A, Martin LS, Alimonti A, Valente C, Tormenta S. Efficacy and safety of viscosupplementation by ultrasound-guided intraarticular injection in osteoarthritis of the hip. Osteoarthr Cartil. 2003;11:305–306. doi:10.1016/S1063-4584(03)00008-612681959
   PubMed Web of Science ®Google Scholar
• Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27–33. doi:10.1046/j.1365-2796.1997.00170.x9260563
   PubMed Web of Science ®Google Scholar
• Band PA, Heeter J, Wisniewski HG, et al. Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthr Cartil. 2015;23(1):70–76. doi:10.1016/j.joca.2014.09.01725266961
   PubMed Web of Science ®Google Scholar
• Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 1967;10(4):357–376. doi:10.1002/art.17801004076046018
   PubMed Web of Science ®Google Scholar
• Balazs EA, Denlinger JL. Sodium hyaluronate and joint function. Equine Vet Sci. 1985;5:217–228. doi:10.1016/S0737-0806(85)80102-7
   Google Scholar
• Bothner H, Wik O. Rheology of hyaluronate. Acta Otolaryngol Suppl. 1987;442:25–30. doi:10.3109/000164887091028343481162
   PubMedGoogle Scholar
• Cullis-Hill D, Ghosh P. The role of hyaluronic acid in joint stability–a hypothesis for hip dysplasia and allied disorders. Med Hypotheses. 1987;23(2):171–185. doi:10.1016/0306-9877(87)90153-83614011
   PubMed Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Engström-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44(12):817–822. doi:10.1136/ard.44.12.8174083937
   PubMed Web of Science ®Google Scholar
• Collins MN, Birkinshaw C. Physical properties of crosslinked hyaluronic acid hydrogels. J Mater Sci Mater Med. 2008;19(11):3335–3343. doi:10.1007/s10856-008-3476-418528637
   PubMed Web of Science ®Google Scholar
• Highley CB, Prestwich GD, Burdick JA. Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr Opin Biotechnol. 2016;40:35–40. doi:10.1016/j.copbio.2016.02.00826930175
   PubMed Web of Science ®Google Scholar
• Finelli I, Chiessi E, Galesso D, Renier D, Paradossi G. Gel-like structure of a hexadecyl derivative of hyaluronic acid for the treatment of osteoarthritis. Macromol Biosci. 2009;9(7):646–653. doi:10.1002/mabi.v9:719384977
   PubMed Web of Science ®Google Scholar
• Finelli I, Chiessi E, Galesso D, Renier D, Paradossi G. A new viscosupplement based on partially hydrophobic hyaluronic acid: a comparative study. Biorheology. 2011;48(5):263–275. doi:10.3233/BIR-2011-059622433568
   PubMed Web of Science ®Google Scholar
• Priano F. Early Efficacy of Intra-Articular HYADD® 4 (Hymovis®) Injections for Symptomatic Knee Osteoarthritis. Joints. 2017;5(2):79–84. doi:10.1055/s-0037-1603677.29114635
   PubMedGoogle Scholar
• Bisicchia S, Bernardi G, Tudisco C. HYADD 4 versus methylprednisolone acetate in symptomatic knee osteoarthritis: a single-centre single blind prospective randomised controlled clinical study with 1-year follow-up. Clin Exp Rheumatol. 2016;34(5):857–863.27244700
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Massafra U, et al. Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthr Cartil. 2005;13(12):1126–1127. doi:10.1016/j.joca.2005.08.00116242357
   PubMed Web of Science ®Google Scholar
• Migliore A, Bizzi E, Massafra U, Alimonti A, Martin S, Tormenta S. 18 months follow-up after intra-articular administration of Hyalubrix® in 344 patients with symptomatic osteoarthritis of the hip. Osteoarth Cartil. 2008;16(S4):S118–S119. doi:10.1016/S1063-4584(08)60306-4
   Google Scholar
• Migliore A, Tormenta S, Massafra U, et al. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin. 2008;24(5):1309–1316. doi:10.1185/030079908X29193018373891
   PubMed Web of Science ®Google Scholar
• Migliore A, Massafra U, Bizzi E, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11(6):R183. doi:10.1186/ar287520003205
   PubMed Web of Science ®Google Scholar
• Migliore A, Massafra U, Bizzi E, et al. Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study. Arch Orthop Trauma Surg. 2011;131(12):1677–1685. doi:10.1007/s00402-011-1353-y21814776
   PubMed Web of Science ®Google Scholar
• Migliore A, Massafra U, Frediani B, et al. HyalOne® in the treatment of symptomatic hip OA - data from the ANTIAGE register: seven years of observation. Eur Rev Med Pharmacol Sci. 2017;21(7):1635–1644.28429341
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Laganà B, et al. Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE register. Eur Rev Med Pharmacol Sci. 2013;17(13):1752–1759.23852899
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502. doi:10.1136/ard.16.4.49413498604
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI Guidelines for the Non-Surgical Management of Knee, Hip, and Polyarticular Osteoarthritis. Osteoarthr Cartil. 2019;27(11):S1063-4584(19)31116–1.
   Web of Science ®Google Scholar
• Rando G, Pastorino R, Chiacchio F, Franzé F. Valutazione degli effetti a lungo termine del trattamento intrarticolare dell’anca con un acido ialuronico reticolare in sportivi affetti da coxartrosi (Long-term effects of intra-articular hip treatment using a reticular hyaluronic acid in sportsmen affected by hip osteoarthritis). Oral communication to the 7th National ANTIAGE Symposium; 10 2018; Rome, Italy.
   Google Scholar
• Pavelka K, Niethard FU, Giordan N. A multicentre, international, double blind, randomized, placebo - controlled study to assess the efficacy and safety of 2 different regimens of HYADD4-G in knee osteoarthritis. Osteoarthr Cartil. 2010;18(Supplement 2):S45–S256. doi:10.1016/S1063-4584(10)60353-6
   Web of Science ®Google Scholar
• Bernetti A, Santilli V. Prospective, Monocentric, Post-CE Mark Study to Assess Efficacy and Safety of Hymovis One (32 Mg/4 Ml) Intra-Articular Injection in Active Patients Affected by Knee Overuse Syndrome. Abstract to the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO). Rome: Abstract Book; 4 2019:342–343. Available from: https://www.wco-iof-esceo.org/sites/wco19/pdf/WCO19-AbstractBook.pdf. Accessed 1019, 2019.
   Google Scholar
• Migliore A, Tormenta S, Martin LS, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol. 2005;24(3):285–289. doi:10.1007/s10067-004-1009-115592903
   PubMed Web of Science ®Google Scholar
• Kocak D, Annaswamy T, Chong S, Arora R. Development of systemic inflammatory polyarthritis after zygapophyseal joint injection with hylan G-F 20 (synvisc-one). Am J Phys Med Rehabil. 2018;97(2):147–149. doi:10.1097/PHM.000000000000079728708631
   PubMed Web of Science ®Google Scholar
• Zhao H, Liu H, Liang X, Li Y, Wang J, Liu C. Hylan G-F 20 versus low molecular weight hyaluronic acids for knee osteoarthritis: a meta-analysis. BioDrugs. 2016;30(5):387–396. doi:10.1007/s40259-016-0186-127435213
   PubMed Web of Science ®Google Scholar